RTV 5 - Tablet - (5mg)

Rosuvastatin Calcium tablet is indicated for:

Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.

Patients with hypertriglyceredemia as an adjunct to diet.

Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.

... Read moreRovast tablet is indicated for:

Patients with primary hyperlipidemia and mixed dyslipidemia as an adjunct to diet to reduce elevated total-C, LDL-C, ApoB, non HDL-C and TG levels and to increase HDL-C.

Patients with hypertriglyceredemia as an adjunct to diet.

Patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet.

Patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C, total-C, and ApoB.

Slowing the progression of atherosclerosis as part of a treatment strategy to lower total-C and LDL-C as an adjunct to diet.

Pediatric patients 10 to 17 years of age with heterozygous familial hypercholesterolemia (HeFH) to reduce elevated total-C, LDL-C and ApoB after failing an adequate trial of diet therapy.

Risk reduction of Myocardial Infarction (MI), stroke and arterial revascularization procedures in patients without clinically evident CHD, but with multiple risk factors.

Rosuvastatin is contraindicated if-

Known hypersensitivity to product components

Liver disease, which may include unexplained persistent elevations in hepatic transaminase levels

Pregnant women and women who may become pregnant

Nursing mothers

Rosuvastatin Calcium is generally well tolerated. The most frequent adverse events thought to be related to Rosuvastatin Calcium were headache, myalgia, constipation, asthenia, abdominal pain and nausea.